Literature DB >> 11029636

Localization of nAChR subunit mRNAs in the brain of Macaca mulatta.

Z Y Han1, N Le Novère, M Zoli, J A Hill, N Champtiaux, J P Changeux.   

Abstract

We present here a systematic mapping of nAChR subunit mRNAs in Macaca mulatta brain. A fragment, from the transmembrane segments MIII to MIV of Macaca neuronal nAChR subunits was cloned, and shown to exhibit high identity (around 95%) to the corresponding human subunits. Then, specific oligodeoxynucleotides were synthesized for in situ hybridization experiments. Both alpha4 and beta2 mRNA signals were widely distributed in the brain, being stronger in the thalamus and in the dopaminergic cells of the mesencephalon. Most brain nuclei displayed both alpha4 and beta2 signals with the exception of some basal ganglia regions and the reticular thalamic nucleus which were devoid of alpha4 signal. alpha6 and beta3 mRNA signals were selectively concentrated in the substantia nigra and the medial habenula. The strongest signals for alpha3 or beta4 mRNAs were found in the epithalamus (medial habenula and pineal gland), whereas there were no specific alpha3 or beta4 signals in mesencephalic dopaminergic nuclei. alpha5 and alpha7 mRNA signals were found in several brain areas, including cerebral cortex, thalamus and substantia nigra, although at a lower level than alpha4 and beta2. The distribution of alpha3, alpha4, alpha5, alpha6, alpha7, beta2, beta3 and beta4 subunit mRNAs in the monkey is substantially similar to that observed in rodent brain. Surprisingly, alpha2 mRNA signal was largely distributed in the Macaca brain, at levels comparable with those of alpha4 and beta2. This observation represents the main difference between rodent and Macaca subunit mRNA distribution and suggests that, besides alpha4beta2*, alpha2beta2* nAChRs constitute a main nAChR isoform in primate brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029636     DOI: 10.1046/j.1460-9568.2000.00262.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  59 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Miguel Ruiz; Mick'l Scadden; Sean Christensen; Joanna Gajewiak; Layla Azam; J Michael McIntosh
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

3.  Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.

Authors:  Susmita Chatterjee; Pia Steensland; Jeffrey A Simms; Joan Holgate; Jotham W Coe; Raymond S Hurst; Christopher L Shaffer; John Lowe; Hans Rollema; Selena E Bartlett
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

Review 4.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

5.  Translational implications of the anatomical nonequivalence of functionally equivalent cholinergic circuit motifs.

Authors:  Anita A Disney; Jason S Robert
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 6.  Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

Authors:  Maryka Quik; Xiomara A Perez; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 8.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

9.  A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.

Authors:  Bhagirathi Dash; Ronald J Lukas; Ming D Li
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

10.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.